| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-07 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-07 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-06 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |